StockWatch
·

PUNJAB CHEMICALS AND CROP PROTECTION LTD.-$ Q2 FY27 Results

PUNJABCHEMQ2 FY27 Results
Filing
Result:Weak· Market: Down#Margin squeeze#Cost led
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue326.705.9%28.0%
Total Income329.095.4%26.0%
Expenditure310.802.2%29.9%
PBT18.2939.2%16.4%
Net Profit13.4639.0%27.4%
OPM9.04%2.71pp1.24pp
NPM4.09%2.25pp3.01pp
EPS10.9839.0%27.4%
View full financials

Despite 28% YoY revenue growth, adjusted PAT fell 27.4% YoY (and 39% QoQ) as raw-material costs outpaced sales and higher finance costs squeezed OPM to 9.05% — below both the year-ago 10.28% and management's own 12% starting guidance.

Q2 FY-2027 RESULTS · PUNJABCHEM

Punjab Chemicals Q2 FY27: consolidated PAT -27% YoY on margin squeeze, revenue +28%

PAT -27.4% YoY · revenue +28% · margins compressing

03 Nov 2026 · 3 min read
Revenue

₹326.7 Cr

+28% YoY

PAT (consolidated)

₹13.46 Cr

-27.4% YoY

Net margin

4.09%

-3pp YoY

EPS

₹10.98

Punjab Chemicals and Crop Protection's consolidated PAT fell 27.4% YoY to ₹13.46 Cr (₹18.54 Cr a year ago) and 39.0% QoQ (₹22.07 Cr in Q1 FY27), even as consolidated revenue from operations grew 28.0% YoY to ₹326.70 Cr, though it slipped 5.9% QoQ from ₹347.24 Cr. Basic EPS came in at ₹10.98 versus ₹15.12 a year ago and ₹18.00 last quarter. Standalone PAT of ₹13.89 Cr fell a comparatively milder 20.1% YoY, pointing to an added drag from the Belgian subsidiary, SD Agchem (Europe) NV, at the consolidated level. There were no exceptional items in either the current or year-ago quarter, so the decline is entirely on operating performance, not one-offs.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹326.7 Cr-5.9%+28%
Expenses₹310.8 Cr-2.2%+29.9%
PAT₹13.46 Cr-39%-27.4%
Net margin4.09%-2.3pp-3pp
EPS₹10.98-39%-27.4%

The compression sits on the gross-margin line: cost of materials consumed rose to 62.1% of revenue (₹202.75 Cr) from 55.5% a year ago (₹141.57 Cr), outpacing the 28% topline growth and dragging the EBITDA margin (OPM) down to 9.05% from 11.75% in Q1 FY27 and 10.28% a year ago. Finance costs compounded the squeeze, up 50% YoY to ₹5.67 Cr, as the company leaned more on debt: current borrowings jumped to ₹212.79 Cr from ₹104.95 Cr at FY26-end and non-current borrowings to ₹71.75 Cr from ₹37.42 Cr. Net profit margin fell to 4.12% from 7.27% YoY and 6.34% in Q1 FY27.

₹
865.25949.61,033.951,118.31,202.65897.907-3108-2409-1610-0911-03Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹897.9, down 13.7% over the past month of trading.

₹ Cr
08.2416.4824.7220.63Q1 FY26rev ₹320 Cr18.54Q2 FY26rev ₹255 Cr13.81Q3 FY26rev ₹247 Cr10.98Q4 FY26rev ₹209 Cr22.07Q1 FY27rev ₹347 Cr13.46Q2 FY27rev ₹327 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (1 FY-2027 call)
FY27 revenue growth 15-20% (from ₹1,030 Cr base = ₹1,185-1,236 Cr); EBITDA margin gradual improvement to 15% over 2-3 years from current ~12%; new products target 15-18% of revenue; Greenfield CAPEX start in FY27.

— This quarter: missed

On guidance, management's FY27 target of 15-20% revenue growth (to ₹1,185-1,236 Cr from a ₹1,030 Cr base) remains on track — H1 FY27 consolidated revenue of ₹673.94 Cr is up 17.3% YoY, inside that band. But the EBITDA margin trajectory is moving the wrong way: management had guided a gradual climb to 15% over 2-3 years from a ~12% base, and this quarter printed 9.05%, below even that starting point. We found no analyst consensus for this quarter — Punjab Chemicals carries thin formal coverage with no published revenue/PAT estimates — so the print can't be graded against street numbers, and the company issued no accompanying press release with this filing. Trade receivables more than doubled to ₹453.92 Cr from ₹203.50 Cr at FY26-end, driving H1 operating cash flow to a negative ₹99.40 Cr versus a positive ₹82.96 Cr a year ago and funding the higher borrowings and finance costs above. Separately, the company disclosed a ₹44.96 Cr IGST refund litigation win in August 2026, which is not reflected as income in this quarter's P&L.

  • W1

    EBITDA margin recovery toward management's ~12%-to-15% medium-term target after slipping to 9.05% in Q2 FY27

  • W2

    Trade receivables collection and operating cash flow — H1 FY27 was negative ₹99.40 Cr; a reversal is needed to arrest the borrowing-led rise in finance costs

  • W3

    Full-year FY27 revenue tracking against the 15-20% growth guidance (₹1,185-1,236 Cr) given H1 revenue of ₹673.94 Cr

No exceptional items in current or year-ago quarter (the ₹2.08 Cr 'Impact of New Labour Codes' item is FY26 full-year only, not quarterly); figures converted ₹Lakh→₹Cr; OPM computed as (PBT − other income + finance cost + depreciation)/revenue to match our prior-period methodology, which reproduces the context's Q1 FY27 and Q2 FY26 OPM figures exactly.

Informational and educational content only. Not investment advice.